 | Accelerate molecular simulations for your drug discovery research, with Accelrys Discovery Studio ® 3.5!
Designed to address the modeling challenge's faced by research scientists, Discovery Studio 3.5 is Accelrys' latest, and most complete modeling and simulation solution for small molecules and macromolecules-based drug design. Register for our webinar and learn about Accelrys Discovery Studio. | |
| Health Care & Policy |  |  | | - Alliance sounds alarm over effect of sequestration on FDA user fees
The Alliance for a Stronger FDA has expressed concern that the FDA could lose about $94 million in fees from drug and device makers under federal cuts that may be required in January under the Budget Control Act. "This cut would be a devastating blow to the public health and medical benefits and the consumer protections that all Americans derive from an adequately funded FDA," according to the alliance, whose membership includes BIO. Clinica (subscription required) (9/14)       - Horizon's combo drug Duexis cuts ulcer risk in study
A study found that Horizon Pharma's arthritis drug Duexis, which combines famotidine and ibuprofen, reduces ulcer risk caused by ibuprofen alone. Researchers said half as many patients using Duexis had an ulcer after 24 weeks compared with those taking ibuprofen alone. Duexis is marketed as a more convenient alternative to a nonsteroidal anti-inflammatory drug with a separate gastroprotective agent. Medscape (free registration) (9/14)  |  |  | | How to turn money you already spend into points you can use:
The Business Gold Rewards Card from American Express OPEN, designed to earn Membership Rewards® points faster: 3X on airfare, 2X on advertising, gas & shipping. 1X on everything else. Use points to pay for travel, Amazon.com purchases, Facebook ads, and more. Limited Time Offer: 50K bonus points when you spend $5K in your first 3 months of Card membership†
LEARN MORE & APPLY †Terms & Restrictions Apply. | |  |  |  |
  | Company & Financial News | | | | | Global Developments | | | | - UCB opens biotech plant in Belgium
UCB has opened an $85 million biotechnology facility at its site in Braine-L'Alleud, Belgium. The plant, which will become fully operational next year, will manufacture cell culture-based therapeutic proteins and support the firm's biologics research and trials. "With this bio pilot plant, we will more rapidly initiate clinical studies of new antibody-based therapeutics that are addressing serious unmet medical needs," CEO Roch Doliveux said. InPharm.com (9/17)
| Food & Agriculture | | | | - Council will promote use of agricultural biotechnology in Australia
AusBiotech, the National Farmers' Federation, the Grains Research and Development Corporation and CropLife Australia have joined forces to establish the Agricultural Biotechnology Council of Australia to promote the use of biotechnology and gene technology in farming. "Biotechnology innovations ensure that Australian farmers can supply food, while reducing the environmental foot print of agriculture through reduced use of pesticides and other environmental contaminants," said AusBiotech CEO Anna Lavelle, who will serve as the council's non-executive director. Australian Life Scientist (9/18) | Industrial & Environmental | | | | - Deinove achieves proof-of-concept for bacteria-aided ethanol process
France-based Deinove, which is developing an ethanol production method that uses Deinococcus bacteria and wheat-based feedstock, will receive $1.5 million from the French government after achieving its proof-of-concept target. Deinove says its technology converts biomass into fermentable sugars and turns those sugars into ethanol in a single step, eliminating the need for additives. Now in the pilot laboratory phase, the company's aim is to produce several hundred liters of ethanol. EthanolProducer.com (9/14) | News from BIO | | | | - BIOtechNOW
BIOtechNOW is the first in a number of new products from BIO intended to enhance our communications with the biotech community -- not only with our members, but with other stakeholders as well. This e-newsletter, combined with its website, serves as our flagship in that effort. BIOtechNOW will offer original content that emphasizes the business needs of the industry; highlight BIO's advocacy efforts; and provide a portal to all BIO activities and events. Most importantly, it will spotlight for those outside the industry the value of biotechnology. Sign up for the e-newsletter.
| SmartQuote | | | |  | The secret of managing is to keep the guys who hate you away from the guys who are undecided."
--Casey Stengel,
American baseball player and manager  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Monday, September 17, 2012
- Friday, September 14, 2012
- Thursday, September 13, 2012
- Wednesday, September 12, 2012
- Tuesday, September 11, 2012
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2012 SmartBrief, Inc.® Legal Information |
|
1 comment:
Great post. I used to be checking continuously this weblog and I’m impressed! Extremely helpful information specially the remaining phase I maintain such information a lot. I was looking for this certain info for a very lengthy time. Thanks and best of luck.CSC Pharmaceuticals International is a foremost Indian Pharmaceutical wholesaler dealing in a wide array of top quality, comparator, managed and rare to find pharmaceutical products.Oncology Drug Products.
Post a Comment